Guangdong Taienkang Pharmaceutical Co., Ltd.

XSEC:301263 Stock Report

Market Cap: CN¥5.5b

Guangdong Taienkang Pharmaceutical Co., Ltd. Company Information

Guangdong Taienkang Pharmaceutical Co., Ltd.'s employee growth, exchange listings and data sources


Key Information

  • Name: Guangdong Taienkang Pharmaceutical Co., Ltd.
  • Ticker: 301263
  • Exchange: XSEC
  • Founded: 1999
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: CN¥5.514b
  • Shares Outstanding: 423.51m
  • Website: https://www.tai-kang.com.cn

Number of Employees


Location

  • Guangdong Taienkang Pharmaceutical Co., Ltd.
  • Building A
  • No. 8, Wanji South 2nd Street
  • Shantou
  • Guangdong Province
  • 515041
  • China


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
301263SZSE (Shenzhen Stock Exchange)YesDomestic SharesCNCNYMar 2022
301263XSEC (Shenzhen Stock Exchange - Shenzhen-Hong Kong Stock Connect)YesDomestic SharesCNCNYMar 2022

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/06/20 00:00
End of Day Share Price 2024/06/20 00:00
Earnings2024/03/31
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.